
Bumrungrad International Hospital, a global leader in quaternary care, proudly announces the introduction of Photon-counting CT technology, the latest advancement in diagnostic imaging. This revolutionary innovation marks a significant milestone in early disease detection, patient safety, and personalized treatment, reinforcing Bumrungrad's commitment to medical excellence.
The press conference, "Unlock the Future of Screening & Diagnostics with Photon Counting CT Technology," took place at the Queen Sirikit National Convention Center, where leading experts discussed the transformative impact of this breakthrough on various medical fields.
Mr. Barry Wolfman, Senior Executive Director of Operations of Bumrungrad International Hospital, emphasized the hospital's dedication to cutting-edge medical innovation, "At Bumrungrad, we are committed to redefining healthcare through technological advancements that enhance patient safety, improve diagnostic accuracy, and promote early disease detection. The introduction of Photon-counting CT technology represents a major step forward in precision medicine, ensuring that our patients receive the most advanced, effective, and safe care available."
Mr. Chris Poray, Managing Director of Siemens Healthineers Thailand, reaffirms commitment to pioneering breakthroughs in healthcare for everyone, everywhere, sustainably through patient-centered innovation. "Siemens Healthneers leverages its strengths in patient twinning, precision therapy, and digital, data, and AI technologies to overcome major diseases like Cancer, Neurovascular and Cardiovascular conditions. NAEOTOM Alpha, the world's first photon-counting CT is a testament to this commitment. This next-generation CT scanner offers unprecedented clarity and precision, allowing for earlier detection and effective treatment planning. We are honored to collaborate with Bumrungrad, a hospital renowned for its medical excellence, to bring this groundbreaking technology to patients in Thailand and beyond."
A panel discussion featuring leading experts in radiology, neurology, pulmonology, cardiology, and genetics explored the impact of Photon-counting CT across various specialties:
Vithya Varavithya, MD, Chief of Section Body Imaging, Department of Radiology and Radiologist at Bumrungrad International Hospital, highlighted the significant benefits of the new technology for radiologists and patients, "Photon-counting CT provides higher resolution images with reduced noise, allowing for earlier and more accurate detection of diseases. Additionally, it minimizes radiation exposure, making CT scans safer, particularly for frequent screenings, such as coronary arterial disease, CT lung screening and pediatric imaging. This represents a breakthrough in diagnostic confidence."
Roekchai Tulyapronchote, MD, Director of Neuroscience Center and Neurologist at Bumrungrad International Hospital, explained the impact on stroke management, "In neurology, time is critical?especially for stroke patients. Photon-counting CT enables faster, more precise brain imaging, allowing us to detect strokes earlier and initiate treatment sooner. This technology significantly improves patient outcomes by reducing brain damage and enhancing recovery potential."
Chok Limsuwat, MD, Assistant Professor, Pulmonologist at Bumrungrad International Hospital, addressed "With Thailand's increasing air pollution concerns, early lung disease detection is more critical than ever. This technology allows us to identify small pulmonary nodules and detect lung cancer at an earlier stage, leading to timely interventions and improved patient survival rates."
Manasawee Vassara, MD, Cardiologist at Bumrungrad International Hospital, underscored the benefits for heart disease prevention, "Heart disease remains one of the leading causes of death worldwide. Photon-counting CT enhances the detection of coronary artery disease, calcium scoring, and plaque differentiation. With this advanced imaging, we can provide non-invasive, highly accurate assessments, enabling early interventions that improve long-term cardiac health."
Polakit Teekakirikul, MD, Assistant Professor, Chief Science Officer, Cardiologist, and Medical Geneticist at Bumrungrad International Hospital, emphasized the technology's role in preventive medicine, "Photon-counting CT is a game-changer for preventive healthcare. It allows us to detect diseases before symptoms appear, improving patient outcomes through early intervention. At Bumrungrad, we are proud to be the first hospital in Thailand to offer this cutting-edge technology, setting new standards in diagnostic precision."
Bumrungrad International Hospital's integration of Photon-counting CT technology reflects its unwavering dedication to innovation, patient safety, and medical excellence. As a leader in global healthcare, Bumrungrad continues to drive advancements that enhance early detection, personalized treatment, and long-term health outcomes.